Immunic Inc. (IMUX) Tops Q2 EPS by 1c

Immunic Inc. (NASDAQ: IMUX) reported Q2 EPS of ($0.72), $0.01 better than the analyst estimate of ($0.73).

For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.

You May Also Be Interested In

• Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
• The Children's Place (PLCE) PT Lowered to $3.25 at UBS on Soft Sales Trends
• Signet shares jump on Q2 profit beat, raised annual guidance